Goebell PJ - Search Results

1

Concepts for banking tissue in urologic oncology--the International Bladder Cancer Bank.

Goebell PJ, Groshen S, Schmitz-Dräger BJ, Sylvester R, Kogevinas M, Malats N, Sauter G, Grossman HB, Dinney CP, Waldman F, Cote RJ. Goebell PJ, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):413-5. Clin Cancer Res. 2005. PMID: 15701822 Review. No abstract available.

2

Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients.

Lieb V, Abdulrahman A, Weigelt K, Hauch S, Gombert M, Guzman J, Bellut L, Goebell PJ, Stöhr R, Hartmann A, Wullich B, Taubert H, Wach S. Lieb V, et al. Among authors: goebell pj. Cells. 2022 Nov 15;11(22):3618. doi: 10.3390/cells11223618. Cells. 2022. PMID: 36429046 Free PMC article.

3

Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma.

Kümmerl L, Kraulich M, Lesyuk W, Binninger A, Goebell PJ, Kahlmeyer A. Kümmerl L, et al. Among authors: goebell pj. Urol Oncol. 2023 Sep;41(9):392.e1-392.e9. doi: 10.1016/j.urolonc.2023.06.011. Epub 2023 Jul 12. Urol Oncol. 2023. PMID: 37442742 Free article.

4

The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape.

Doehn C, Bögemann M, Grünwald V, Welslau M, Bedke J, Schostak M, Wolf T, Ehneß R, Degenkolbe E, Witecy S, Goebell PJ. Doehn C, et al. Among authors: goebell pj. Cancers (Basel). 2022 Nov 8;14(22):5486. doi: 10.3390/cancers14225486. Cancers (Basel). 2022. PMID: 36428579 Free PMC article.

5

p53 and MDM2 in the development and progression of bladder cancer.

Schmitz-Dräger BJ, Kushima M, Goebell P, Jax TW, Gerharz CD, Bültel H, Schulz WA, Ebert T, Ackermann R. Schmitz-Dräger BJ, et al. Eur Urol. 1997;32(4):487-93. Eur Urol. 1997. PMID: 9412812

6

p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?

Schmitz-Dräger BJ, Goebell PJ, Ebert T, Fradet Y. Schmitz-Dräger BJ, et al. Among authors: goebell pj. Eur Urol. 2000 Dec;38(6):691-9;discussion 700. doi: 10.1159/000020364. Eur Urol. 2000. PMID: 11111186

7

p21 and p53 Immunostaining and survival following systemic chemotherapy for urothelial cancer.

Jankevicius F, Goebell P, Kushima M, Schulz WA, Ackermann R, Schmitz-Dräger BJ. Jankevicius F, et al. Urol Int. 2002;69(3):174-80. doi: 10.1159/000063949. Urol Int. 2002. PMID: 12372883

8

Environmental exposure, chlorinated drinking water, and bladder cancer.

Goebell PJ, Villanueva CM, Rettenmeier AW, Rübben H, Kogevinas M. Goebell PJ, et al. World J Urol. 2004 Feb;21(6):424-32. doi: 10.1007/s00345-003-0389-1. Epub 2003 Dec 20. World J Urol. 2004. PMID: 14689225

9

Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma.

Chatterjee SJ, Datar R, Youssefzadeh D, George B, Goebell PJ, Stein JP, Young L, Shi SR, Gee C, Groshen S, Skinner DG, Cote RJ. Chatterjee SJ, et al. Among authors: goebell pj. J Clin Oncol. 2004 Mar 15;22(6):1007-13. doi: 10.1200/JCO.2004.05.174. Epub 2004 Feb 23. J Clin Oncol. 2004. PMID: 14981105

10

Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.

Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK, Jones PA, Cordon-Cardo C, Datar RH, Cote RJ. Chatterjee SJ, et al. Among authors: goebell pj. J Pathol. 2004 Jul;203(3):762-70. doi: 10.1002/path.1567. J Pathol. 2004. PMID: 15221935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters